Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients. - Su, Tung ‐ Hung; Hu, Tsung ‐ Hui; Chen, Chi ‐ Yi; Huang, Yi ‐ Hsiang; Chuang, Wan ‐ Long; Lin, Chun ‐ Che; Wang, Chia ‐ Chi; Su, Wei ‐ Wen; Chen, Ming ‐ Yao; Peng, Cheng ‐ Yuan; Chien, Rong ‐ Nan; Huang, Yi ‐ Wen; et al. (Liver International, 2016)